annual FCF:
-$376.22M-$75.89M(-25.27%)Summary
- As of today (July 4, 2025), RXRX annual free cash flow is -$376.22 million, with the most recent change of -$75.89 million (-25.27%) on December 31, 2024.
- During the last 3 years, RXRX annual FCF has fallen by -$177.81 million (-89.62%).
- RXRX annual FCF is now -621.64% below its all-time high of -$52.13 million, reached on December 31, 2020.
Performance
RXRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$133.79M-$16.71M(-14.27%)Summary
- As of today (July 4, 2025), RXRX quarterly free cash flow is -$133.79 million, with the most recent change of -$16.71 million (-14.27%) on March 31, 2025.
- Over the past year, RXRX quarterly FCF has dropped by -$24.84 million (-22.80%).
- RXRX quarterly FCF is now -283.16% below its all-time high of $73.05 million, reached on March 31, 2022.
Performance
RXRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$401.06M-$24.84M(-6.60%)Summary
- As of today (July 4, 2025), RXRX TTM free cash flow is -$401.06 million, with the most recent change of -$24.84 million (-6.60%) on March 31, 2025.
- Over the past year, RXRX TTM FCF has dropped by -$70.43 million (-21.30%).
- RXRX TTM FCF is now -2067.75% below its all-time high of -$18.50 million, reached on March 31, 2020.
Performance
RXRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
RXRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.3% | -22.8% | -21.3% |
| 3 y3 years | -89.6% | -283.2% | -433.4% |
| 5 y5 years | -517.2% | -623.1% | -1019.2% |
RXRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -211.2% | at low | -153.7% | at low | -253.6% | at low |
| 5 y | 5-year | -621.6% | at low | -283.2% | at low | -1019.2% | at low |
| alltime | all time | -621.6% | at low | -283.2% | at low | -2067.8% | at low |
RXRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$133.79M(+14.3%) | -$401.06M(+6.6%) |
| Dec 2024 | -$376.22M(+25.3%) | -$117.08M(+83.5%) | -$376.22M(+12.1%) |
| Sep 2024 | - | -$63.79M(-26.2%) | -$335.63M(-2.9%) |
| Jun 2024 | - | -$86.40M(-20.7%) | -$345.60M(+4.5%) |
| Mar 2024 | - | -$108.95M(+42.4%) | -$330.63M(+10.1%) |
| Dec 2023 | -$300.33M(+148.4%) | -$76.49M(+3.7%) | -$300.33M(+8.6%) |
| Sep 2023 | - | -$73.75M(+3.2%) | -$276.56M(+4.0%) |
| Jun 2023 | - | -$71.44M(-9.2%) | -$265.92M(-2.4%) |
| Mar 2023 | - | -$78.66M(+49.2%) | -$272.58M(+125.5%) |
| Dec 2022 | -$120.88M | -$52.73M(-16.4%) | -$120.88M(-9.6%) |
| Sep 2022 | - | -$63.10M(-19.2%) | -$133.78M(+17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$78.10M(-206.9%) | -$113.43M(+50.8%) |
| Mar 2022 | - | $73.05M(-211.3%) | -$75.19M(-62.1%) |
| Dec 2021 | -$198.41M(+280.6%) | -$65.62M(+53.5%) | -$198.41M(+54.0%) |
| Sep 2021 | - | -$42.75M(+7.2%) | -$128.81M(+21.1%) |
| Jun 2021 | - | -$39.87M(-20.5%) | -$106.34M(+26.9%) |
| Mar 2021 | - | -$50.17M(-1359.9%) | -$83.80M(+60.7%) |
| Dec 2020 | -$52.13M(-14.5%) | - | - |
| Dec 2020 | - | $3.98M(-119.6%) | -$52.13M(-7.1%) |
| Sep 2020 | - | -$20.28M(+17.0%) | -$56.12M(+56.6%) |
| Jun 2020 | - | -$17.33M(-6.3%) | -$35.83M(+93.7%) |
| Mar 2020 | - | -$18.50M | -$18.50M |
| Dec 2019 | -$60.95M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual FCF year-on-year change?
- What is Recursion Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
- What is Recursion Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM FCF year-on-year change?
What is Recursion Pharmaceuticals annual free cash flow?
The current annual FCF of RXRX is -$376.22M
What is the all time high annual FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual free cash flow is -$52.13M
What is Recursion Pharmaceuticals annual FCF year-on-year change?
Over the past year, RXRX annual free cash flow has changed by -$75.89M (-25.27%)
What is Recursion Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RXRX is -$133.79M
What is the all time high quarterly FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly free cash flow is $73.05M
What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RXRX quarterly free cash flow has changed by -$24.84M (-22.80%)
What is Recursion Pharmaceuticals TTM free cash flow?
The current TTM FCF of RXRX is -$401.06M
What is the all time high TTM FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM free cash flow is -$18.50M
What is Recursion Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RXRX TTM free cash flow has changed by -$70.43M (-21.30%)